drugset / Trial / NCT05286281
A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetics, excretion, mass balance and metabolism of PF-07265803 (formerly known as ARRY-371797) in approximately 6 healthy adult male participants.
Timeline
- Start
- 2022-03-31
- Primary completion
- 2022-05-26
- Completion
- 2022-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-07265803 | Unknown | — | Oral |
Indications
No indication recorded.